You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •EEG
 •Alert me on articles by topic

Quantitative Spectral Electroencephalography in Predicting Survival in Patients With Early Alzheimer Disease

Jules J. Claus, MD, PhD; Bram W. Ongerboer de Visser, MD, PhD; Gerard J. M. Walstra, MD, PhD; Albert Hijdra, MD, PhD; Bernard Verbeeten, Jr, MD, PhD; Willem A. van Gool, MD, PhD

Arch Neurol. 1998;55:1105-1111.

Objective  To determine whether measures of quantitative spectral electroencephalography (EEG) can predict survival in patients with early Alzheimer disease.

Design  Prospective cohort study; median duration of follow-up was 4.4 years in survivors and 2.6 years in nonsurvivors. Cox proportional hazards models, with adjustment for age and sex were used to estimate relationships between EEG measures and survival. Log relative percentage values of EEG bands were used as predictors.

Setting  Outpatient university memory clinic.

Participants  One hundred one consecutively referred patients with early probable Alzheimer disease according to National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association criteria were studied with EEG at the time of diagnosis. The mean age of the patients was 79.2 years, which was higher than in previous EEG studies.

Main Outcome Measure  Mortality.

Results  Fifty-one patients (50.5%) died during follow-up, with a median survival time in all patients of 4.1 years. The following EEG variables were significantly associated with increased risk of mortality: from parieto-occipital leads, higher theta (hazard ratio, 2.05; 95% confidence interval, 1.15-3.66; P<.05), lower alpha (hazard ratio, 0.43; 95% confidence interval, 0.25-0.76; P<.01), and lower beta (hazard ratio, 0.38; 95% confidence interval, 0.22-0.68; P<.001) activity; and from frontocentral leads, higher theta activity (hazard ratio, 2.07; 95% confidence interval, 1.17-3.66; P<.05). Stepwise Cox regression analysis showed that loss of parieto-occipital beta (P<.01) and alpha (P<.05) power were independent and significant predictors of mortality. Both beta (12.6-35.4 Hz) and alpha (7.5-12.5 Hz) activity remained significantly associated with mortality after adjustment for education, dementia severity, symptom duration, level of cognitive function, presence of extrapyramidal symptoms or hallucinations, presence of vascular risk factors, and presence of leukoaraiosis or local cortical atrophy.

Conclusions  Decreases of beta and alpha activity on quantitative spectral EEG are independent predictors of mortality in patients with early Alzheimer disease. In the clinical context, the use of EEG technology for prediction of survival in individual patients remains to be determined.


From the Department of Neurology (Drs Claus, Walstra, Hijdra, and van Gool), Division of Clinical Neurophysiology (Drs Claus and Ongerboer de Visser), and Department of Radiology (Dr Verbeeten), Academic Medical Center, Amsterdam, the Netherlands.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive Predictors of Mortality in Elderly Retirees: Results From the Freedom House Study
Royall et al.
AJGP 2007;15:243-251.
ABSTRACT | FULL TEXT  

Small-World Networks and Functional Connectivity in Alzheimer's Disease
Stam et al.
Cereb Cortex 2007;17:92-99.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.